tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
KNSA is currently covered by 5 analysts with an average price target of $43.11. This is a potential upside of $14.7 (51.74%) from yesterday's end of day stock price of $28.41.
Kiniksa Pharmaceuticals Ltd's activity chart (see below) currently has 47 price targets and 43 ratings on display. The stock rating distribution of KNSA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 54% with an average time for these price targets to be met of 690.8 days.
Highest price target for KNSA is $40, Lowest price target is $34, average price target is $36.2.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 16-Apr-2025. First documented stock forecast 18-Jun-2018.
Currently out of the existing stock ratings of KNSA, 14 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$34
$5.7 (20.14%)
$34
2 months ago
(16-Apr-2025)
6/10 (60%)
$13.46 (65.53%)
751
Buy
$40
$11.7 (41.34%)
$28
3 months 3 days ago
(13-Mar-2025)
3/6 (50%)
$17.84 (80.51%)
585
Buy
$40
$11.7 (41.34%)
$39
7 months 11 days ago
(05-Nov-2024)
6/10 (60%)
$17.97 (81.57%)
348
Buy
$35
$6.7 (23.67%)
$30
7 months 18 days ago
(29-Oct-2024)
4/8 (50%)
$11.73 (50.41%)
776
Buy
$32
$3.7 (13.07%)
$24
1 years 10 months 22 days ago
(25-Jul-2023)
4/8 (50%)
$12.52 (64.27%)
994
What is KNSA (Kiniksa Pharmaceuticals Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on KNSA (Kiniksa Pharmaceuticals Ltd) with a proven track record?
Which analyst has the current lower performing score on KNSA (Kiniksa Pharmaceuticals Ltd) with a proven track record?
Which analyst has the most public recommendations on KNSA (Kiniksa Pharmaceuticals Ltd)?
Which analyst is the currently most bullish on KNSA (Kiniksa Pharmaceuticals Ltd)?
Which analyst is the currently most reserved on KNSA (Kiniksa Pharmaceuticals Ltd)?
